| American heart association council on E, prevention statistics c, stroke statistics s. heart disease and stroke statistics-2019 update: a report from the American heart association EJ Benjamin, P Muntner, A Alonso, MS Bittencourt, CW Callaway, ... Circulation 139 (10), e56-e528, 2019 | 510 | 2019 |
| Biomarkers for the diagnosis and management of heart failure V Castiglione, A Aimo, G Vergaro, L Saccaro, C Passino, M Emdin Heart failure reviews, 1-19, 2022 | 229 | 2022 |
| Prognostic value of soluble suppression of tumorigenicity-2 in chronic heart failure: a meta-analysis A Aimo, G Vergaro, C Passino, A Ripoli, B Ky, WL Miller, A Bayes-Genis, ... JACC: Heart Failure 5 (4), 280-286, 2017 | 216 | 2017 |
| Statin therapy in COVID-19 infection V Castiglione, M Chiriacò, M Emdin, S Taddei, G Vergaro European Heart Journal-Cardiovascular Pharmacotherapy 6 (4), 258-259, 2020 | 213 | 2020 |
| Prognostic value of high-sensitivity troponin T in chronic heart failure: an individual patient data meta-analysis A Aimo, JL Januzzi Jr, G Vergaro, A Ripoli, R Latini, S Masson, M Magnoli, ... Circulation 137 (3), 286-297, 2018 | 204 | 2018 |
| sST2 predicts outcome in chronic heart failure beyond NT− proBNP and high-sensitivity troponin T M Emdin, A Aimo, G Vergaro, A Bayes-Genis, J Lupón, R Latini, ... Journal of the American College of Cardiology 72 (19), 2309-2320, 2018 | 191 | 2018 |
| Multiparametric echocardiography scores for the diagnosis of cardiac amyloidosis M Boldrini, F Cappelli, L Chacko, MA Restrepo-Cordoba, A Lopez-Sainz, ... Cardiovascular Imaging 13 (4), 909-920, 2020 | 179 | 2020 |
| Meta-analysis of soluble suppression of tumorigenicity-2 and prognosis in acute heart failure A Aimo, G Vergaro, A Ripoli, A Bayes-Genis, DA Pascual Figal, ... JACC: Heart Failure 5 (4), 287-296, 2017 | 165 | 2017 |
| Treatment of cardiac transthyretin amyloidosis: an update M Emdin, A Aimo, C Rapezzi, M Fontana, F Perfetto, PM Seferović, ... European Heart Journal 40 (45), 3699-3706, 2019 | 150 | 2019 |
| Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week A Aimo, JL Januzzi, A Bayes-Genis, G Vergaro, P Sciarrone, C Passino, ... Journal of the American College of Cardiology 74 (17), 2193-2203, 2019 | 149 | 2019 |
| Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice G Vergaro, M Prud’Homme, L Fazal, R Merval, C Passino, M Emdin, ... Hypertension 67 (3), 606-612, 2016 | 123 | 2016 |
| Markers of fibrosis, inflammation, and remodeling pathways in heart failure C Passino, A Barison, G Vergaro, A Gabutti, C Borrelli, M Emdin, A Clerico Clinica Chimica Acta 443, 29-38, 2015 | 118 | 2015 |
| Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta‐analysis of screening studies A Aimo, M Merlo, A Porcari, G Georgiopoulos, L Pagura, G Vergaro, ... European journal of heart failure 24 (12), 2342-2351, 2022 | 100 | 2022 |
| RNA-targeting and gene editing therapies for transthyretin amyloidosis A Aimo, V Castiglione, C Rapezzi, M Franzini, G Panichella, G Vergaro, ... Nature Reviews Cardiology 19 (10), 655-667, 2022 | 92 | 2022 |
| Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week M Emdin, A Aimo, V Castiglione, G Vergaro, G Georgiopoulos, ... Journal of the American College of Cardiology 76 (15), 1795-1807, 2020 | 91 | 2020 |
| Keys to early diagnosis of cardiac amyloidosis: red flags from clinical, laboratory and imaging findings G Vergaro, A Aimo, A Barison, D Genovesi, G Buda, C Passino, M Emdin European journal of preventive cardiology 27 (17), 1806-1815, 2020 | 85 | 2020 |
| Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy G Vergaro, A Del Franco, A Giannoni, C Prontera, A Ripoli, A Barison, ... International journal of cardiology 184, 96-100, 2015 | 84 | 2015 |
| Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction G Vergaro, N Ghionzoli, L Innocenti, C Taddei, A Giannoni, A Valleggi, ... Journal of the American Heart Association 8 (20), e013441, 2019 | 82 | 2019 |
| Prognostic significance of myocardial extracellular volume fraction in nonischaemic dilated cardiomyopathy A Barison, A Del Torto, S Chiappino, GD Aquaro, G Todiere, G Vergaro, ... Journal of Cardiovascular Medicine 16 (10), 681, 2015 | 82 | 2015 |
| CHADS2 and CHA2DS2-VASc scores to predict morbidity and mortality in heart failure patients candidates to cardiac resynchronization therapy A Paoletti Perini, S Bartolini, P Pieragnoli, G Ricciardi, L Perrotta, ... Europace 16 (1), 71-80, 2014 | 81 | 2014 |
